D-0248-2018 Class III Terminated

Recalled by Ascent Pharmaceuticals, Inc. — Central Islip, NY

FDA drug recall D-0248-2018 was initiated by Ascent Pharmaceuticals, Inc. on Jan 22, 2018 and is designated Class III. Reason for recall: Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol The recall status is terminated (terminated Apr 23, 2018). Affected quantity: 45,875 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 7, 2018
Initiation Date
Jan 22, 2018
Termination Date
Apr 23, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
45,875 bottles

Product description

Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY --- NDC 31722-917-01

Reason for recall

Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol

Distribution pattern

Nationwide

Code information

Lot Numbers: 17080591 and 17080619, exp 07/19; 17110907 and 17110908, exp 10/19; and 17120986, exp 11/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0248-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0248-2018. Report a data issue: hello@regdatalab.com.